LL-37 Research Peptide | Biovantage Labs

LL-37 Research Peptide | Biovantage Labs

LL-37 is the only known human cathelicidin antimicrobial peptide, studied for its roles in innate immunity, direct antimicrobial activity, wound healing, and immunomodulatory signalling research models. Biovantage Labs supplies LL-37 at 99+% purity, verified by batch-specific HPLC and Mass Spectrometry. Domestically fulfilled from Canada. Not for human consumption.

$70.00

Description

LL-37 Biovantage Labs Research Peptide

LL-37 is the only known human cathelicidin antimicrobial peptide, studied for its roles in innate immunity, direct antimicrobial activity, wound healing, and immunomodulatory signalling research models. Biovantage Labs supplies LL-37 at 99+% purity, verified by batch-specific HPLC and Mass Spectrometry. Domestically fulfilled from Canada. Not for human consumption. Biovantage Labs provides this compound at 99+% purity, confirmed by batch-specific HPLC and Mass Spectrometry analysis, as a lyophilized compound for use in controlled laboratory settings.

Molecular Profile and Chemical Specifications

Specification Detail
Molecular Formula C205H340N60O53S2
Molecular Weight 4,493.3 Da
Sequence LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES (37 AA)
Purity ≥99+% (HPLC/MS verified)
Physical Form Lyophilized white powder
CAS Number 154947-66-7

 

Primary Research Mechanisms

Antimicrobial peptide research examining innate immune defence alongside anti-inflammatory mechanisms often includes KPV as a complementary research tool. KPV’s NF-kB inhibitory properties and antimicrobial activity represent a structurally simpler (tripeptide vs. 37-residue) but mechanistically distinct approach to the same dual antimicrobial/anti-inflammatory research questions.

Membrane Disruption and Direct Antimicrobial Activity

LL-37 adopts an amphipathic alpha-helical conformation that inserts into and disrupts bacterial and fungal membranes. Research has examined its minimum inhibitory concentrations against gram-positive, gram-negative, and fungal species in microbiology studies.

TLR Signalling Modulation in Innate Immunity

LL-37 modulates innate immune signalling by suppressing TLR4-mediated LPS recognition, reducing excessive inflammatory responses in sepsis models. It simultaneously activates FPRL1 (formyl peptide receptor-like 1), demonstrating bidirectional immunomodulatory research applications.

Wound Healing and Angiogenesis Research

In wound healing research models, LL-37 stimulates keratinocyte migration, re-epithelialization, and angiogenesis. Studies have examined VEGF pathway interactions as a downstream consequence of LL-37’s wounding response signalling.

For innate immunity research examining multiple arms of the immune response, Thymosin Alpha-1 is studied in adjacent contexts, its TLR2/TLR9 pathway activation and dendritic cell maturation properties representing an adaptive immunity dimension that complements LL-37’s innate antimicrobial and TLR4 modulation research profile.

Reconstitution Protocol

  • Reconstitute using sterile bacteriostatic water or 0.9% sodium chloride solution
  • Introduce diluent slowly along the interior vial wall do not inject directly onto the lyophilized cake
  • Swirl gently until fully dissolved do not shake or vortex
  • Allow the vial to equilibrate to room temperature before opening to prevent condensation

Storage and Stability

Storage Condition State Estimated Stability
-20°C to -80°C Lyophilized 24+ months
2°C to 8°C Lyophilized 12 months
Room temperature (20°C) Lyophilized 3 months
2°C to 8°C Reconstituted 7 to 14 days

 

Store in a desiccated environment away from UV exposure. Avoid repeated freeze-thaw cycles, which degrade peptide chain integrity over time.

LL-37 Research FAQ

Q: Why is LL-37 unique among human antimicrobial peptides?

A: LL-37 is the only cathelicidin expressed in humans. While most mammals express multiple cathelicidins, humans produce only this single member of the family. This uniqueness makes LL-37 the sole model for studying human cathelicidin biology, giving it a distinct and non-redundant position in innate immunity research.

Q: Is LL-37 for human use?

A: No. LL-37 supplied by Biovantage Labs is strictly for laboratory research purposes. It is not approved for human consumption, veterinary use, or clinical application.

Q: What purity standard does Biovantage Labs apply?

A: Every batch is verified at 99+% purity using HPLC to confirm compound concentration and Mass Spectrometry to confirm molecular identity. Batch-specific COA documentation is available upon request.

Q: Where does Biovantage Labs ship from?

A: All Biovantage Labs products are fulfilled domestically from within Canada, eliminating customs clearance risk and reducing transit time compared to international suppliers.

Reviews

There are no reviews yet.

Be the first to review “LL-37 Research Peptide | Biovantage Labs”

Your email address will not be published. Required fields are marked *

Related Products

High Quality Research Peptides You Can Trust

Explore premium-grade peptides for scientific research, purity tested, lab certified, and shipped discreetly.